118 related articles for article (PubMed ID: 37708114)
1. Animal efficacy study of a plant extract complex (BEN815) as a potential treatment for COVID-19.
Do MH; Li H; Cho SY; Oh S; Jeong JH; Song MS; Jeong JM
PLoS One; 2023; 18(9):e0291537. PubMed ID: 37708114
[TBL] [Abstract][Full Text] [Related]
2. The potential of BEN815 as an anti-inflammatory, antiviral and antioxidant agent for the treatment of COVID-19.
Shin JA; Oh S; Jeong JM
Phytomed Plus; 2021 Nov; 1(4):100058. PubMed ID: 35403084
[TBL] [Abstract][Full Text] [Related]
3. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
4. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Therapeutic Potential of 6,6'-Dihydroxythiobinupharidine (DTBN) from
Weiss S; Waidha K; Rajendran S; Benharroch D; Khalilia J; Levy H; Bar-David E; Golan-Goldhirsh A; Gopas J; Ben-Shmuel A
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176034
[TBL] [Abstract][Full Text] [Related]
6. Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice.
Seo SM; Son JH; Lee JH; Kim NW; Yoo ES; Kang AR; Jang JY; On DI; Noh HA; Yun JW; Park JW; Choi KS; Lee HY; Shin JS; Seo JY; Nam KT; Lee H; Seong JK; Choi YK
PLoS One; 2022; 17(7):e0272019. PubMed ID: 35881617
[TBL] [Abstract][Full Text] [Related]
7. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice.
Liu JF; Peng WJ; Wu Y; Yang YH; Wu SF; Liu DP; Liu JN; Yang JT
EBioMedicine; 2023 Apr; 90():104518. PubMed ID: 36933413
[TBL] [Abstract][Full Text] [Related]
8. Animal Models of COVID-19: Transgenic Mouse Model.
Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
[TBL] [Abstract][Full Text] [Related]
9. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
[TBL] [Abstract][Full Text] [Related]
10. The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.
Liu X; Mostafavi H; Ng WH; Freitas JR; King NJC; Zaid A; Taylor A; Mahalingam S
mBio; 2022 Jun; 13(3):e0068322. PubMed ID: 35420469
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model.
Cáceres CJ; Cardenas-Garcia S; Carnaccini S; Seibert B; Rajao DS; Wang J; Perez DR
Sci Rep; 2021 May; 11(1):9609. PubMed ID: 33953295
[TBL] [Abstract][Full Text] [Related]
13. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological potential of
Rizvi ZA; Babele P; Madan U; Sadhu S; Tripathy MR; Goswami S; Mani S; Dikshit M; Awasthi A
Front Immunol; 2023; 14():1138215. PubMed ID: 36960064
[TBL] [Abstract][Full Text] [Related]
15. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.
Colunga Biancatelli RML; Solopov PA; Sharlow ER; Lazo JS; Marik PE; Catravas JD
Am J Physiol Lung Cell Mol Physiol; 2021 Aug; 321(2):L477-L484. PubMed ID: 34156871
[TBL] [Abstract][Full Text] [Related]
16. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
[TBL] [Abstract][Full Text] [Related]
17. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.
Kumari P; Rothan HA; Natekar JP; Stone S; Pathak H; Strate PG; Arora K; Brinton MA; Kumar M
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477869
[TBL] [Abstract][Full Text] [Related]
18. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of K18-
Moreau GB; Burgess SL; Sturek JM; Donlan AN; Petri WA; Mann BJ
Am J Trop Med Hyg; 2020 Sep; 103(3):1215-1219. PubMed ID: 32723427
[TBL] [Abstract][Full Text] [Related]
20. Osteoclast-mediated bone loss observed in a COVID-19 mouse model.
Awosanya OD; Dalloul CE; Blosser RJ; Dadwal UC; Carozza M; Boschen K; Klemsz MJ; Johnston NA; Bruzzaniti A; Robinson CM; Srour EF; Kacena MA
Bone; 2022 Jan; 154():116227. PubMed ID: 34607050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
